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Abstract
 
T cell homing to peripheral lymph nodes (PLNs) is defined by a multistep sequence of interactions
 
between lymphocytes and endothelial cells in high endothelial venules (HEVs). After initial
tethering and rolling via L-selectin, firm adhesion of T cells requires rapid upregulation of lym-
 
phocyte function–associated antigen 1 (LFA-1) adhesiveness by a previously unknown pathway that
 
activates a G
 
a
 
i
 
-linked receptor. Here, we used intravital microscopy of murine PLNs to study
 
the role of thymus-derived chemotactic agent (TCA)-4 (secondary lymphoid tissue chemokine,
6Ckine, Exodus-2) in homing of adoptively transferred T cells from T-GFP mice, a transgenic
strain that expresses green fluorescent protein (GFP) selectively in naive T lymphocytes (T
 
GFP
 
cells). TCA-4 was constitutively presented on the luminal surface of HEVs, where it was required
 
for LFA-1 activation on rolling T
 
GFP
 
 cells. Desensitization of the TCA-4 receptor, CC chemo-
 
kine receptor 7 (CCR7), blocked T
 
GFP
 
 cell adherence in wild-type HEVs, whereas desensitization
 
to stromal cell–derived factor (SDF)-1
 
a
 
 (the ligand for CXC chemokine receptor 4 [CXCR4])
did not affect T
 
GFP
 
 cell behavior. TCA-4 protein was not detected on the luminal surface of
 
PLN HEVs in 
 
plt/plt
 
 mice, which have a congenital defect in T cell homing to PLNs. Accord-
ingly, T
 
GFP
 
 cells rolled but did not arrest in 
 
plt/plt
 
 HEVs. When TCA-4 was injected intracuta-
neously into 
 
plt/plt 
 
mice, the chemokine entered afferent lymph vessels and accumulated in
draining PLNs. 2 h after intracutaneous injection, luminal presentation of TCA-4 was detect-
able in a subset of HEVs, and LFA-1–mediated T
 
GFP
 
 cell adhesion was restored in these vessels.
We conclude that TCA-4 is both required and sufficient for LFA-1 activation on rolling T cells
in PLN HEVs. This study also highlights a hitherto undocumented role for chemokines con-
tained in afferent lymph, which may modulate leukocyte recruitment in draining PLNs.
Key words: homing • intravital microscopy • adhesion • T cell
 
Introduction
 
T lymphocytes continuously recirculate through the body,
traveling from the blood through tissues, and via lymphatic
vessels and the thoracic duct back into the blood (1–3).
Secondary lymphoid organs, such as spleen, peripheral LNs
(PLNs),
 
1
 
 mesenteric LNs (MLNs), and Peyer’s patches (PPs)
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Abbreviations used in this paper: 
 
CCR, CC chemokine receptor; CXCR,
CXC chemokine receptor; DC, dendritic cell; DNP, dinitrophenol; EC,
endothelial cell; GFP, green fluorescent protein; HEV, high endothelial
venule; MIP, macrophage inflammatory protein; MLN, mesenteric LN;
PLN, peripheral LN; 
 
plt
 
, paucity in LN T cells; PNAd, peripheral node
addressin; PP, Peyer’s patch; PTX, pertussis toxin; SDF, stromal cell–
derived factor; TCA, thymus-derived chemotactic agent. 
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are sites of intense lymphocyte trafficking. Tissue-specific
homing of blood-borne naive lymphocytes into secondary
lymphoid tissues is critical to ensure frequent and efficient
encounters between APCs and antigen-specific T cells (3, 4).
The cutaneous hypersensitivity reaction is a good exam-
ple for illustrating the importance of T cell homing to PLNs.
In this setting, antigen that penetrates the skin is taken up
by Langerhans cells. Subsequently, these professional APCs
enter afferent lymph vessels, which channel cells and inter-
stitial fluid to local PLNs (4). The antigen-laden APCs then
induce the activation, expansion, and differentiation of an-
tigen-specific T cells that must enter skin-draining PLNs
from the blood. Within a few days, primed T cells leave the
PLNs and migrate to the skin. Upon renewed cutaneous ex-
posure to antigen, these cells mediate a local inflammatory
 
(delayed-type hypersensitivity) response. This sequence is
disrupted in L-selectin (CD62L)-deficient mice, because
their T cells cannot home to PLNs where antigen is presented
(5). Thus, L-selectin–deficient animals respond poorly to
cutaneous antigen unless T cell homing to PLNs is tempo-
rarily restored (5, 6).
Recently, the adhesion cascade that governs lymphocyte
homing to PLNs has been partially elucidated (7). Circulat-
ing lymphocytes must first adhere to microvascular endo-
thelial cells (ECs) in the presence of hydrodynamic shear
exerted by the flowing blood. An initial tether is formed by
L-selectin, which binds to the peripheral node addressin
(PNAd), a mixture of sialylated, fucosylated, and sulfated gly-
coproteins that are selectively expressed in specialized post-
capillary microvessels, the high endothelial venules (HEVs)
(8, 9). L-selectin interaction with PNAd allows lymphocytes
to roll in HEVs at a velocity that is much slower than that
of noninteracting cells (10). Within seconds after initial
 
contact, a fraction (
 
z
 
20–30%) of rolling lymphocytes arrest
firmly (“stick”), a process that requires the 
 
b
 
2-integrin
LFA-1 (CD11a/CD18) (7). The sequential engagement of
L-selectin and LFA-1 is a prerequisite for subsequent ex-
travasation of lymphocytes in PLNs (11–15).
However, expression of L-selectin and LFA-1 alone is
not sufficient for homing to PLNs. Both are abundantly ex-
pressed on other leukocytes, including granulocytes, which
do not home to PLNs. Granulocytes undergo L-selectin–
mediated rolling interactions in PLN HEVs, but they do
not stick (7). A likely explanation for this observation is the
fact that L-selectin binding to PNAd is independent of a
cell’s activation state, whereas LFA-1 must be functionally
activated (16). The intracellular events that lead to LFA-1
activation are believed to be triggered by chemoattractant
receptors on the lymphocyte surface. Accordingly, LFA-1
activation in PLN HEVs is blocked by pertussis toxin (PTX)-
mediated ADP-ribosylation of G
 
a
 
i
 
, the regulatory subunit
of large heterotrimeric G proteins. Pretreatment of lym-
phocytes with PTX abrogates LFA-1–dependent sticking
in PLN HEVs (7, 17). Thus, it has been hypothesized that
LFA-1 activation requires stimulation of a G protein–cou-
pled receptor that is expressed on lymphocytes, but not
granulocytes (2, 3, 7). Chemokines are likely candidates to
provide such a stimulus, as they bind G
 
a
 
i
 
-linked receptors
whose expression is often restricted to distinct leukocyte
subsets (18, 19).
Several chemokines possess potent and selective chemoat-
tractant activity for naive lymphocytes (19). One of these is
thymus-derived chemotactic agent (TCA)-4 (secondary
lymphoid-tissue chemokine [SLC], 6Ckine, or Exodus-2),
a CC chemokine that acts on lymphocytes, dendritic cells
(DCs), and mesangial cells, but not on monocytes or gran-
ulocytes (20–23). In chemotaxis assays, TCA-4 attracts T
and B cells; its chemoattractant potency is somewhat higher
on naive than memory T cells (20–24). CC chemokine re-
ceptor (CCR)7, the principal TCA-4 receptor (24, 25), is
expressed on lymphocytes and DCs, but not on granulo-
cytes and monocytes (26, 27). In addition to inducing lym-
phocyte chemotaxis over a time course of minutes to hours,
in vitro experiments have shown that TCA-4 can also trig-
ger much more rapid (within seconds or less) integrin bind-
ing to immobilized intracellular adhesion molecule (ICAM)-1
and mucosal addressin cell adhesion molecule (MAdCAM)-1
under both static and flow conditions (28–30). Studies by
several groups using immunohistology, Northern blots, and
in situ hybridization have shown that TCA-4 is constitu-
tively expressed in secondary lymphoid organs and in lymph
vessels (20–23). The highest mRNA levels were seen in
the T cell area of PLNs, particularly in HEVs (22). Thus,
TCA-4 meets several requirements for a chemoattractant
that might activate LFA-1 on rolling lymphocytes in PLNs:
(a) its receptor, CCR7, is expressed on naive T cells, the
predominant PLN-tropic lymphocyte population; (b) CCR7
activation triggers a rapid integrin response; and (c) TCA-4
is expressed in HEVs, the main port of lymphocyte entry
into PLNs.
Recent experiments in DDD/1-
 
plt/plt
 
 (
 
plt/plt
 
) mice fur-
ther implicate TCA-4 in T cell homing. These mice have an
autosomal recessive gene defect termed 
 
plt
 
 (paucity in LN
T cells). Their PLNs contain few T cells, but normal num-
bers of B cells (31). The few T cells that are present in 
 
plt/
plt
 
 PLNs belong to the memory subset, whereas wild-type
PLNs contain mostly naive T cells (32). Homozygous 
 
plt/
plt
 
 mice have elevated T cell numbers in blood and spleen,
suggesting a selective defect in naive T cell homing to
PLNs. This defect appears to be localized in the PLN stroma,
since adoptively transferred 
 
plt/plt
 
 T cells home normally to
PLNs of wild-type mice, whereas wild-type T cells home
poorly to 
 
plt/plt
 
 PLNs (31, 32). Moreover, B cell homing
to PLNs is essentially normal in 
 
plt/plt
 
 mice, indicating that
the homing defect is not due to a lack of endothelial adhe-
sion molecules (31). Indeed, a recent report has found that
TCA-4 mRNA is absent in PLNs of these mice (33). How-
ever, the available data do not exclude the possibility that
the 
 
plt
 
 mutation affects other genes that could be required
for T cell homing independent of TCA-4. Moreover, it has
not been determined whether TCA-4 protein is absent in
 
plt/plt
 
 PLNs. Conceivably, TCA-4 might be produced in
nonlymphoid tissues of 
 
plt/plt
 
 mice, from where it could be
drained into PLNs via afferent lymph vessels.
Finally, in addition to TCA-4, other chemokines are
present in PLNs that can also activate integrins on rolling T 
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cells in vitro (28). However, this constitutes no proof that
TCA-4 or other chemokines are indeed involved in inte-
grin activation in HEVs, because chemoattractants must be
present on the luminal surface of HEVs. To date, no un-
equivocal evidence has been presented for the presence of a
chemokine in this microanatomical location. Thus, a direct
role for TCA-4 or any other chemokine in the multistep
adhesion cascade of lymphocyte homing in HEVs remains
to be documented.
Here, we used intravital microscopy to investigate the phys-
iological role of TCA-4 in T cell homing to PLNs. TCA-4
was concentrated on the luminal surface of wild-type, but
not 
 
plt/plt
 
 PLN HEVs. To study the effect of TCA-4 spe-
cifically on T cells, we made use of a novel strain of trans-
genic (T-GFP) mice, which express green fluorescent pro-
tein (GFP) under a T cell–specific promoter. Adoptively
transferred naive T lymphocytes (T
 
GFP
 
 cells) from T-GFP
mice were visualized in PLN HEVs of wild-type and 
 
plt/plt
 
mice by epifluorescence illumination. When T
 
GFP
 
 cells were
desensitized to TCA-4, they failed to stick in wild-type
PLNs, whereas desensitization to another chemokine, stro-
mal cell–derived factor (SDF)-1
 
a
 
, had no effect. Upon in-
jection into 
 
plt/plt
 
 mice, T
 
GFP
 
 cells rolled in PLN HEVs,
but did not stick. This defect in 
 
plt/plt
 
 mice was reversed af-
ter intracutaneous injection of TCA-4. The injected chemo-
kine accumulated rapidly in draining PLNs and was detect-
able in a subpopulation of HEVs where it reconstituted
LFA-1–mediated sticking of T
 
GFP
 
 cells. These results docu-
ment a central role for TCA-4 in the subset- and tissue-spe-
cific adhesion cascade that mediates T cell homing to PLNs.
 
Materials and Methods
 
Antibodies and Reagents.
 
Anti-PNAd mAb MECA-79 (rat IgM
[9]) and anti–murine TCA-4 mAbs 4B1 and 3D5 (Armenian hamster
IgG [20]) were generated from culture supernatants. Anti–mouse
LFA-1 mAb TIB 213 (rat IgG2b [34]), FITC-conjugated anti–
murine TCA-4 mAb 4B1 (specific fluorescence to protein [F/P;
mol/mol] ratio 3.74), and FITC-conjugated anti-dinitrophenol
(DNP) mAb (specific F/P ratio 4.20; Armenian hamster IgG) used
as nonbinding control were provided by Dr. Eugene Butcher
(Stanford University, Stanford, CA). Anti–mouse CD16/CD32,
PE-conjugated B220, and PE-conjugated CD3 mAbs were from
PharMingen. Recombinant murine TCA-4 and human SDF-1
 
a
 
were from R&D Systems. For some experiments, we used full-
length and COOH-terminally truncated murine TCA-4 prepared
using the His-patched thioredoxin fusion protein method (20). Ac-
tivity of full-length TCA-4 from both sources was indistinguish-
able in chemotaxis and calcium flux assays (not shown). Truncated
TCA-4 (TCA-4
 
D
 
CT
 
) was generated by introducing a stop codon
after amino acid Q69 (20). Thus, recombinant TCA-4
 
D
 
CT
 
 lacked
the last 41 amino acids of the elongated COOH terminus (20–23).
Human 
 
125
 
I–TCA-4 (96 mCi/mg) was a gift of Dr. Diane True
(New England Nuclear, Boston, MA). FITC-dextran (150 kD)
was purchased from Sigma Chemical Co. Before injection into an-
imals, FITC-dextran was dissolved in sterile saline (10 mg/ml) and
centrifuged to remove insoluble particles.
 
Mice. plt/plt
 
 mice on DDD/1 background (31, 32) were used
for intravital microscopy and as organ donors for most immuno-
histology studies. DDD/1–
 
mtv-2/mtv-2
 
 mice served as wild-type
 
controls (31). BALB/c mice (Charles River) were used to mea-
sure kinetics of intracutaneously injected TCA-4. BALB/c mice
(The Jackson Laboratory) were also used in some immunohistol-
ogy experiments as controls for 
 
plt/plt
 
 mice that were backcrossed
on the BALB/c background (BALB/c-
 
plt/plt
 
) (31). A newly con-
structed transgenic strain termed T-GFP (either FVB or crossed
into C57/BL6/J background) served as the source of T
 
GFP
 
 cells
(35). This study complies with NIH guidelines for the care and
use of laboratory animals and was approved by the Institutional
Review Committees of both Harvard Medical School and The
Center for Blood Research. Mice were housed with free access
to sterilized water and standard lab chow in a specific pathogen-
free and viral antibody-free (SPF/VAF) animal facility at Harvard
Medical School.
 
FACS
 
®
 
 Analysis.
 
Spleens and PLNs of T-GFP mice were
passed through wire mesh in DMEM, 1% FCS, 20 mM Hepes,
pH 7.4, containing 5 mM EDTA and depleted of erythrocytes by
ammonium chloride lysis. After F
 
c
 
 receptors were blocked with
anti-CD16/CD32, cells were stained with PE-conjugated anti-
B220 or anti-CD3 mAb for 20 min on ice. Cells were washed
and analyzed by flow cytometry (FACScan™; Becton Dickinson)
using CELLQuest™ software (Becton Dickinson) after gating for
viable lymphocytes by forward and side scatter characteristics.
 
Preparation of T-GFP Cells.
 
To study selectively naive T cells
in vivo, PLNs and MLNs of T-GFP mice were harvested, passed
through wire mesh, and resuspended in 37
 
8
 
C DMEM, 1% FCS,
20 mM Hepes, pH 7.4. Naive T cells in T-GFP mice (henceforth
called T
 
GFP
 
 cells) uniformly express high levels of GFP, whereas
B cells and other leukocyte subsets do not (35; and this report).
Single cell suspensions from T-GFP mice were injected into
wild-type or 
 
plt/plt
 
 recipients without further purification or la-
beling. For intravital microscopy, lymphocytes were resuspended
to 2 
 
3
 
 10
 
7
 
 cells/ml in prewarmed buffer. For homing experi-
ments, lymphocytes were resuspended to 2 
 
3
 
 10
 
8
 
 cells/ml in
DMEM, 1% FCS, 20 mM Hepes, pH 7.4. The behavior of T
 
GFP
 
cells from animals on FVB or FVB 
 
3 
 
C57/BL6/J background
was indistinguishable in intravital microscopy studies, homing ex-
periments, and chemotaxis assays (not shown). Thus, data from
both cell populations were pooled in Results (see below).
For desensitization, LN cells from T-GFP mice were prepared
as above and incubated at 37
 
8
 
C for 
 
$
 
40 min in DMEM, 1%
FCS, 20 mM Hepes, pH 7.4, containing 1 
 
m
 
M SDF-1
 
a
 
 or TCA-4.
Desensitized cells were washed once, resuspended to 2 
 
3
 
 10
 
7
 
cells/ml, and immediately injected into recipients. Chemokine
exposure did not affect GFP expression in T
 
GFP
 
 cells (not shown).
 
Immunohistology.
 
Inguinal and axillary PLNs from wild-type
and 
 
plt/plt
 
 mice were frozen in OCT compound (TBS). Serial
sections (9 
 
m
 
m) were cut on a Leica cryostat, air dried, fixed in 2%
paraformaldehyde, and incubated overnight at 4
 
8
 
C with anti-PNAd
mAb MECA-79 (10 
 
m
 
g/ml) or a combination of anti–TCA-4
mAbs 4B1 and 3D5 (both at 200 
 
m
 
g/ml). These concentrations
gave maximal signal while keeping background staining low. As a
negative control for mAb MECA-79, rat serum (1:1,000) was
used. After blocking intrinsic avidin/streptavidin, sections were
incubated with biotinylated anti-Armenian hamster Ig (PharMin-
gen) or anti–rat Ig (DAKO), then incubated with streptavidin–
horseradish peroxidase (DAKO) followed by diaminobenzidine
(DAB; Vector Laboratories) and counterstaining with hematoxylin.
 
Homing Assays.
 
5 
 
3
 
 10
 
7
 
 T-GFP cells in 250 
 
m
 
l DMEM, 1%
FCS, 20 mM Hepes, pH 7.4, were injected into the tail vein of age-
and sex-matched DDD/1-
 
plt/plt
 
 and DDD/1–
 
mtv-2/mtv-2
 
 mice.
After 2 h, mice were anesthetized and exsanguinated. Peripheral
blood lymphocytes were isolated by ammonium chloride lysis of red 
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blood cells. Recipient spleens, PLNs, MLNs, and PPs were dissected
and passed through wire mesh. Single cell suspensions were analyzed
by flow cytometry as described above. Data are expressed as percent-
age of GFP
 
1
 
 cells in the total number of gated lymphocytes.
 
Animal Preparation.
 
Mice were anesthetized by intraperito-
neal injection of 10 ml/kg saline containing xylazine (1 mg/ml)
and ketamine (5 mg/ml). The left subiliac (superficial inguinal)
LN was prepared as described (10). In brief, the right femoral ar-
tery was catheterized for injection of cell samples and mAbs. Sub-
sequently, a semicircular incision was made in the lower left ab-
dominal skin. The skin flap was spread on a glass slide on a Plexiglas
stage. The fatty tissue surrounding the exposed LN was removed
without damage to feeding or draining blood vessels. In some ex-
periments, 1 or 2.5 mg TCA-4 or SDF-1a in 50 ml Ringer’s in-
jection solution (Abbott Laboratories) was injected into the epi-
dermis over the left thigh z1 cm distally from the subiliac LN.
Before preparing the LN, mice were allowed to rest for 30–45
min to maintain physiologic interstitial pressure gradients that
may be necessary for chemokine-containing fluids to enter lymph
vessels at the site of injection and for drainage into PLNs.
Distribution of Intracutaneously Injected 125I–TCA-4. To assess the
fate of intracutaneously injected TCA-4, 2.6 ng human 125I–TCA-4
(96 mCi/mg) in 50 ml PBS was injected intracutaneously over
the left anterior hind leg of BALB/c mice (three mice/time
point). 15, 30, 60, 120, and 240 min after injection, mice were
killed, the draining (left) and contralateral (right) subiliac LN and
MLN were removed, and blood was obtained by cardiac puncture.
Tissues were weighed, homogenized, agitated overnight on a shaker
with 2 N NaOH and 0.05% SDS, and counted on a gamma-
counter. The specific radioactivity associated with each organ was
expressed per unit wet weight.
Measurement of TCA-4 by ELISA. Skin draining PLNs (axil-
lary, cervical, and inguinal), MLNs, spleen, thymus, and PPs were
harvested from young adult BALB/c or BALB/c-plt/plt mice.
Some BALB/c-plt/plt mice were injected intracutaneously with
5 mg murine full-length TCA-4 or TCA-4DCT that was equally
distributed among five different injection sites (submandibular in
the midline and bilaterally in ventral forelimbs and inner thighs;
50 ml PBS with 1 mg protein/site). The draining PLNs and other
lymphoid organs were harvested 2 h later. 25 mg tissue was homo-
genized in 0.3 ml PBS with 1 mM PMSF, 0.01 mg/ml leupeptin,
and 0.01 mg/ml aprotinin. Extracts were sonicated, centrifuged,
and supernatants were stored at 2808C. TCA-4 in supernatants
was detected by ELISA using immobilized mAb 4B1 for capture
and biotinylated mAb 3D5 followed by alkaline phosphatase–
coupled avidin (Pierce Chemical Co.) and 5 mM p-nitrophenyl
phosphate (Sigma Chemical Co.) for detection. Both full-length
TCA-4 and TCA-4DCT can be quantified by this method with
comparable sensitivity (not shown). Absorbency was determined at
405 nm with a Vmax® kinetic microplate reader (Molecular De-
vices). TCA-4 concentrations were calculated from standard curves
obtained by titrating known amounts of TCA-4 or TCA-4DCT
into similar tissues from plt/plt mice.
Intravital Microscopy. Anesthetized animals were transferred to
an intravital microscope (model IV-500; Mikron Instruments).
Body temperature was maintained at 378C using a tubular heater.
LN microvessels were observed through a 403 water immersion
objective (Achroplan, NA 0.75; Carl Zeiss, Inc.). For immunolo-
calization of TCA-4 in PLNs and skin, 75 mg FITC-conjugated
mAb 4B1 in 250 ml saline was injected through the femoral ar-
tery catheter and allowed to bind for 5–30 min. In some animals,
75 mg FITC-conjugated anti-DNP mAb was injected as a non-
binding control.
Small boluses (20–50 ml) of LN cell suspensions from T-GFP
mice were retrogradely injected through the femoral artery cath-
eter and visualized in the subiliac LN by fluorescent epiillumination
from a video-triggered xenon arc stroboscope (Chadwick-Hel-
muth) as described (10). This route of injection, directly upstream
of the artery feeding the subiliac LN, allowed us to inject a sec-
ond cell sample while keeping the systemic concentration of pre-
viously injected cells low (7). In some experiments, the role of
LFA-1 in TCA-4–mediated sticking of TGFP cells was assessed.
After recording control TGFP cell behavior without mAb, the
recipient mouse and lymphocytes were treated with 50 mg (intra-
arterial) and 20 mg/ml (5 min at 378C) mAb TIB 213, respec-
tively. Control and mAb-treated TGFP cells were compared in the
same vascular bed. At the end of each experiment, FITC-dextran
(150 kD; 10 mg/kg) was injected to visualize the intravascular
compartment for measurement of vascular dimensions (10). All
scenes were recorded on videotape using a low-lag silicon-inten-
sified target camera (model VE1000SIT; Dage MTI), a time base
generator (For-A Corp. Ltd.), and a Sony Hi-8 VCR (model
ECV-100).
Image Analysis. Video analysis was carried out off-line as de-
scribed (36). Rolling (i.e., cells that interacted visibly with HEVs
and traveled at a slower velocity than the blood stream) and non-
interacting TGFP cells were counted in each venule. The rolling
fraction was calculated as percentage of rolling cells among the
total number of TGFP cells that entered a venule. The sticking
fraction was determined as percentage of TGFP cells becoming
firmly adherent for .20 s in the number of TGFP cells that rolled
in a venule during the same time interval. Only venules in which
$10 rolling cells were recorded were considered for analysis of
sticking fractions. TGFP cell adhesion was also analyzed in some
HEVs with high blood flow that were located relatively deep
within the LN. As the optical properties of these vessels were of-
ten suboptimal, it was not always possible to be certain that every
fast moving noninteracting TGFP cell could be detected. In con-
trast, rolling and sticking TGFP cells produced a stronger signal in
our camera and were reliably detected and quantified. Thus, only
the sticking fraction was determined in these vessels. Lumenal
cross-sectional diameters of FITC-dextran–filled vessels were
measured using a customized image analysis system (37).
Statistical Analysis. Data are presented as mean 6 SEM, un-
less otherwise indicated. For comparison of rolling and sticking
fractions of different cell samples recorded in the same prepara-
tion, a paired Student’s t test was used. For comparison of rolling
and sticking fractions between different mouse preparations, the
unpaired Student’s t test was used. Significance was set at P , 0.05.
Online Supplemental Data. Digitized QuickTime™ videos show-
ing characteristic scenes from intravital microscopy experiments
of TGFP cell behavior and TCA-4 staining in wild-type and plt/plt
mice are available at http://www.jem.org/cgi/content/full/191/1/
61/DC1 (see legends to Figs. 2, 4, 6, and 7).
Results
TCA-4 Protein Is Presented on the Luminal Surface of PLN
HEVs in Wild-Type, but Not plt/plt Mice. This study was
conducted to test the hypothesis that the chemokine TCA-4
mediates T cell homing to PLNs by activating LFA-1 on roll-
ing T cells in HEVs. Our hypothesis was based on the recent
finding that TCA-4 mRNA is expressed in PLN HEVs in
wild-type mice (22), but not in plt/plt mice (33), which also
have a striking defect in T cell homing to PLNs (31, 32). To65 Stein et al.
determine whether the lack of TCA-4 message is reflected at
the protein level, we performed immunohistology on serial LN
sections from wild-type (DDD/1–mtv-2/mtv-2 or BALB/c)
and plt/plt mice. To identify HEVs, we used mAb MECA-79
against PNAd, an L-selectin ligand that stains PLN HEVs of all
strains (31). Of 109 PNAd1 HEVs that were identified in ad-
jacent serial sections of wild-type PLNs (n 5 3), 94 (86%) also
stained with anti–TCA-4 (Fig. 1, A and B). In addition, single
cells that were sparsely scattered throughout the T cell area
stained weakly with anti–TCA-4. No staining was detected in
B cell follicles (not shown). Although PNAd expression in
plt/plt mice was comparable to wild-type mice (Fig. 1 C),
Figure 1. Expression of PNAd
and TCA-4 in wild-type and plt/
plt PLNs. Serial sections (9 mm)
of wild-type (A and B) or plt/plt
PLNs (C and D) were stained for
PNAd (mAb MECA-79; A and C)
or TCA-4 (mAbs 3D5 and 4B1;
B and D). PNAd (A) and TCA-4
(B) are colocalized in wild-type
HEVs. Although PNAd expres-
sion is normal in plt/plt HEVs
(C), no TCA-4 can be detected
in these animals (D). Original
magnification:  31,000.
Figure 2. TCA-4 is presented
on the luminal surface of wild-
type, but not plt/plt, venules in
PLNs. Fluorescent microvessels
were recorded in anesthetized
wild-type and plt/plt mice after
intravenous injection of 75 mg
anti–mouse TCA-4 mAb FITC-
4B1. (A) PLN microvessels in a
wild-type mouse. Note that flu-
orescent anti–TCA-4 delineates
the HEV, but not an adjacent ar-
teriole (ART). (B) Skin venules
(VEN) or arterioles (ART) in
the same wild-type mouse did
not stain with anti–TCA-4. (C)
FITC-4B1 did not accumulate
in PLN venules of plt/plt mice. The extravascular bright spots were already present before
mAb injection. These spots are most likely autofluorescent cells in the superficial cortex that
are occasionally encountered in wild-type as well as plt/plt PLNs. Similar results were ob-
tained in two other wild-type and plt/plt preparations. Bar, 100 mm. Digitized Quick-
Time™ videos showing characteristic scenes from intravital TCA-4 staining in wild-type
and  plt/plt mice (corresponding to A and C, respectively) are available at http://
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anti–TCA-4 did not bind detectably to HEVs or any other
structure in plt/plt PLNs (Fig. 1 D).
The immunohistology technique used above does not have
sufficient spatial resolution to distinguish between intracellular
and surface-expressed antigen. We reasoned that HEV-associ-
ated TCA-4 in wild-type mice could only activate rolling T
cells if it was presented on the luminal surface of HEVs. To
address this issue in vivo, we injected FITC-conjugated anti–
TCA-4 mAb 4B1 (75 mg intraarterial) into wild-type mice
and observed the LN microvasculature by intravital micros-
copy as described (38). Within a few minutes after mAb injec-
tion, a striking accumulation of fluorescence was noted at the
walls of most postcapillary and collecting venules, but not in
arterioles or capillaries (Fig. 2 A). Maximum staining of PLN
venules was observed after z30 min, whereas no fluorescence
was seen at any time point in the surrounding skin (Fig. 2 B).
Consistent with the results obtained by immunohistology, no
staining with anti–TCA-4 was observed anywhere within plt/
plt  LNs (Fig. 2 C). Injection of an equivalent amount of
FITC-conjugated control mAb revealed no detectable staining
in either mouse strain (not shown).
Use of TGFP Cells for In Vivo Studies of T Cell Migration.
Having confirmed that TCA-4 is expressed in HEVs of wild-
type but not plt/plt PLNs, we asked whether this defect in
plt/plt mice affects integrin activation on rolling lympho-
cytes. The plt mutation affects only T cell homing, whereas
B cell migration is essentially normal (31, 32). Thus, it was
necessary to study selectively T cell adhesion in PLN HEVs.
For this purpose, we made use of transgenic T-GFP mice (35).
The T-GFP transgene incorporates the promoter and proxi-
mal enhancer of murine CD4 (39) and pEGFP-C1 cDNA
(Clontech), a red-shifted variant of wild-type GFP (P64L
and S65T mutations), which is detectable by epifluorescence
through an FITC filter set (35). The transcriptional control
elements from the CD4 locus induced uniform GFP expres-
sion in essentially all naive CD41 and CD81 T cells (collec-
tively called TGFP cells). Other leukocyte subsets did not ex-
press the transgene (35; Fig. 3 A).
Experiments using flow cytometry and histology revealed
no difference in size, cellularity, or composition of lymphoid
organs in T-GFP mice compared with nontransgenic con-
trols (35; and data not shown). To rigorously exclude that
GFP expression in TGFP cells had altered the cells’ ability to
home to PLNs, we performed short-term homing assays. 2 h
after adoptive transfer, 6.0 6 0.9% (mean 6 SD; n 5 6) of
resident lymphocytes in PLNs of wild-type recipients were
GFP1 (Fig. 3 B), whereas TGFP cells constituted only 1.3 6
0.3% of lymphocytes in PLNs of plt/plt recipients (n 5 6; P ,
0.0001). On average, the total number of lymphocytes in
wild-type PLNs is five times higher than in plt/plt PLNs
(31; and data not shown). Thus, the absolute number of
TGFP cells that homed to PLNs was at least 20 times higher
in wild-type than in plt/plt mice. In contrast, TGFP homing
to the spleen was similar in both strains (wild-type, 8.6 6
1.8%; plt/plt, 7.7 6 2.8%; P 5 0.31). Conversely, the num-
ber of circulating TGFP cells was larger in plt/plt than in wild-
type mice (11.5 6 3.2 vs. 2.6 6 1.5%; P , 0.0002). These
results are in good agreement with homing studies using
Figure 3. T lymphocytes from T-GFP transgenic mice specifically express GFP and serve as a useful tool for in vivo studies of T cell homing to PLNs.
(A) FACS® analysis of splenocytes and PLN lymphocytes derived from T-GFP transgenic mice. Naive T, but not B cells from T-GFP transgenic mice
specifically express GFP. (B) TGFP homing to PLNs and spleen in wild-type and plt/plt mice. The distribution of TGFP cells was analyzed 2 h after tail vein
injection and expressed as percentage of GFP1 cells among gated lymphocytes in each lymphoid organ and in systemic blood. One representative exper-
iment (out of six performed with similar results) is shown for each recipient strain.67 Stein et al.
nontransgenic T cells (31, 32) and indicate that TGFP cells
are useful for studying T cell migration.
TGFP Cells Roll, but Do Not Arrest, in plt/plt HEVs. To ana-
lyze T cell behavior in PLNs, we generated single cell suspen-
sions from PLNs and MLNs of T-GFP mice. Although
these preparations contained only 60–80% TGFP cells (Fig.
3 A), the cells were injected immediately into recipient mice
without any further purification or labeling. Since TGFP
cells were the only subset carrying a fluorophore, contami-
nating nonfluorescent cells did not affect our analysis because
they remained undetectable under epifluorescent light.
Consistent with the reduction in T cell numbers in plt/plt
PLNs, the size of subiliac LNs appeared smaller and the venu-
lar tree had fewer branches than in wild-type controls (not
shown). Moreover, most venules of the same branching order
had a smaller diameter in plt/plt PLNs. For example, the di-
ameter of order III venules in wild-type PLNs was 51.7 6
6.2 mm (mean 6 SEM; n 5 5) vs. 25.1 6 1.8 mm in plt/plt
PLNs (n 5 9; P , 0.0003). Consequently, the mean rolling
fraction of TGFP was somewhat higher in plt/plt PLNs (Fig. 4,
A and B). It has been shown that rolling fractions tend to be
inversely proportional to the vessel diameter, presumably be-
cause lymphocytes contact ECs more frequently in narrow
vessels (10). No significant difference was found between
wild-type and plt/plt LNs when rolling fractions were com-
pared only in vessels of 25–40 mm diameter (44.2 6 10.5%,
n 5 5, vs. 55.4 6 4.1%, n 5 23, respectively; P 5 0.27).
In wild-type mice, many rolling TGFP cells adhered
firmly (Fig. 4, C and D). The mean sticking fraction in or-
der III and IV venules (21.4 6 2.9%, n 5 5, and 32.4 6
14.2%, n 5 4, respectively) was somewhat higher than pre-
viously published values derived from ex vivo–labeled LN
cells of nontransgenic donors (7, 38; and our unpublished
observations). In contrast, sticking was virtually absent in
plt/plt HEVs. Only 1 cell in .700 rolling TGFP cells analyzed
remained stationary for $20 s, indicating that the transition
from rolling to sticking is severely impaired in plt/plt mice.
Desensitization to TCA-4, but Not SDF-1a, Reduces T Cell
Sticking in Wild-Type PLNs. Our findings in plt/plt mice
pointed to a role for CCR7, the lymphocyte receptor for
TCA-4, in LFA-1 activation on rolling T cells. To investigate
whether the TCA-4/CCR7 pathway is similarly involved in
T cell homing to wild-type PLNs, we took advantage of the
observation that chemokine receptor responsiveness can be
transiently blocked by prolonged exposure to an activating
chemokine (24). TGFP cells were exposed to either 1 mM
TCA-4 or 1 mM SDF-1a ($40 min at 378C). The latter
chemokine does not bind to CCR7, but it activates CXC
chemokine receptor (CXCR)4, which is also expressed on
naive T cells (40, 41). We injected first TCA-4–desensitized
TGFP cells and analyzed their behavior in PLNs within the
first 15 min after desensitization. CCR7 remains refractory to
TCA-4 signaling during this window of time (24). Subse-
quently, SDF-1a–desensitized TGFP cells were recorded in
the same preparation. The rolling fraction of both samples
was similar and did not differ from untreated cells (Fig. 5 A),
indicating that L-selectin function was not impaired by ex-
posing cells to either chemokine. In contrast, TGFP cells that
Figure 4. TGFP cells roll in both wild-type and plt/plt PLNs, but only un-
dergo firm adhesion in wild-type PLN venules. Using intravital microscopy
of murine subiliac PLNs, the behavior of TGFP cells was analyzed. (A) Roll-
ing fractions (determined as the percentage of rolling cells in all cells passing
through a given venule) of TGFP cells in wild-type (1/1) and plt/plt PLN
venules are shown as a function of vessel diameter. Each symbol represents
a single venule. (B) Mean rolling fractions of TGFP cells in wild-type and
plt/plt HEVs. Rolling fractions are slightly elevated in plt/plt mice (*P ,
0.022). (C) Sticking fractions (percentage of rolling cells that arrest for at
least 20 s) of TGFP cells in wild-type and plt/plt PLN venules are shown as a
function of vessel diameter. (D) Mean sticking fractions of TGFP cells in
wild-type and plt/plt PLN venules. Sticking is virtually absent in plt/plt
PLN HEVs (*P , 0.0001). Data in B and D are shown as mean 6 SEM;
n  5  no. of animals/venules analyzed. Digitized QuickTime™ videos
showing characteristic scenes from intravital microscopy experiments of
TGFP cell behavior in wild-type and plt/plt mice are available at http://
www.jem.org/cgi/content/full/191/1/61/F4/DC1.
Figure 5. Desensitization of
CCR7, but not CXCR4, in TGFP
cells blocks firm adhesion in wild-
type PLN venules. TGFP cells
were desensitized by incubation
for  $40 min with 1 mM TCA-4
(agonist for CCR7) or 1 mm
SDF-1a (agonist for CXCR4).
Desensitized cells were sequen-
tially injected into wild-type mice
and observed in identical HEVs.
(A) Mean rolling fractions of
TCA-4– and SDF-1a–desensi-
tized TGFP cells. There was no
statistically significant difference
in rolling fractions. (B) Mean
sticking fraction of TCA-4– and
SDF-1a–desensitized TGFP cells.
TGFP cells desensitized to TCA-4,
but not SDF-1a, failed to un-
dergo firm adhesion in wild-type
PLN venules (*P , 0.03). Data
are shown as mean 6 SEM; n 5
no. of animals/venules analyzed.68 TCA-4 Triggers T Cell Sticking in Lymph Node HEVs
were refractory to TCA-4 arrested poorly in HEVs, whereas
the sticking fraction of TGFP cells desensitized to SDF-1a was
not different from untreated controls (Fig. 5 B). Sticking frac-
tions of SDF-1a–desensitized TGFP cells were similar whether
they were injected with or without prior injection of TCA-
4–treated cells (data not shown). This indicates that the ma-
jority of TGFP cells, which became stuck in PLNs of animals
that had first received TCA-4–treated cells, were SDF-1a–
desensitized TGFP cells, and not rare recirculating TCA-4–
desensitized cells from the prior injection.
Intracutaneously Injected TCA-4 Accumulates in Draining PLNs
and Is Presented on HEVs. The concomitant lack of TCA-4
and TGFP cell sticking in HEVs of plt/plt PLNs was consis-
tent with the idea that TCA-4 is required for LFA-1 acti-
vation. However, these data did not constitute unequivocal
proof for this concept, because it remained theoretically pos-
sible that the plt mutation affected other genes that may be
required in addition to or instead of TCA-4. Therefore, we
asked whether reconstitution of TCA-4 presentation in plt/plt
HEVs could induce TGFP cell sticking. Initially, we super-
fused surgically prepared subiliac LNs in plt/plt mice with a
TCA-4–containing buffer. However, TGFP cell sticking was
not reproducibly induced by this approach (not shown).
We reasoned that the fibrous capsule that covers the LN
might have posed a diffusion barrier. Moreover, the surgi-
cal preparation necessary for microscopic viewing of the
subiliac LN probably altered interstitial pressure gradients,
and, thus, affected chemokine transport via lymph drain-
age. To test whether the chemokine could be transported via
afferent lymph in animals that had not undergone surgery,
Figure 6. Intracutaneously in-
jected TCA-4 specifically accu-
mulates in draining PLNs, where
it is presented on the luminal sur-
face of HEVs. (A) 125I–TCA-4
(2.6 ng in 50 ml saline) was in-
jected into the skin over the left
anterior hind leg of BALB/c mice,
and radioactivity was determined
at time points specified. The activ-
ity of 125I–TCA-4 per mass unit
organ was determined in draining
(left) versus contralateral (right)
subiliac LN and MLN as described
in Materials and Methods. Three
mice per time point after injection
were analyzed. 125I–TCA-4 specif-
ically accumulated in the draining
LN, whereas the contralateral LN
and MLN remained largely unaf-
fected. (B) Intravital micrograph of
fluorescent anti–TCA-4 mAb
FITC-4B1 staining (30 min after
injection of the mAb) in a
branched HEV of a draining subil-
iac LN of a plt/plt mouse 2 h af-
ter intracutaneous injection of
TCA-4. 2.5 mg TCA-4 was in-
jected intracutaneously in the left
hind leg, and the draining subiliac
LN was observed after intraarte-
rial injection of 75 mg anti–TCA-4
mAb FITC-4B1. FITC-4B1 ac-
cumulated in some, but not all
PLN microvessels. Note that the
right venular branch is only par-
tially labeled, and capillaries are
not stained at all (see C). An in-
teracting TGFP cell can be seen in
the right venular branch (arrow).
A digitized QuickTime™ video
of this scene is available at http://
www.jem.org/cgi/content/full/
191/1/61/F6/DC1. (C) Micro-
graph of the same field of view as
in B after injection of FITC-
dextran (150 kD) as a plasma
marker. Note that FITC-dex-
tran,  unlike anti–TCA-4 mAb, delineates all capillaries (CAP) and venules, including the entire length of the HEV that enters the field of view from the right
margin. (D) A skin venule in the same preparation 2 h after intracutaneous injection of TCA-4 and 30 min after injection of anti–TCA-4 mAb FITC-4B1. No
specific fluorescence is associated with these nonlymphoid vessels. (E) Micrograph of the same field of view as in D after injection of FITC-dextran. Bar, 50 mm.69 Stein et al.
we injected 125I–TCA-4 into the skin over the left thigh of
BALB/c mice. 125I–TCA-4 accumulated in the draining (left)
subiliac LN, but not in the contralateral (right) node or in
MLNs (Fig. 6 A). A signal was detected in draining LNs as
early as 15 min after injection. At 4 h, the draining node
contained 20 times more 125I–TCA-4 than the contralateral
node and 10 times more than the peripheral blood (not
shown). High levels of 125I–TCA-4 were also observed in
the kidney (not shown). This probably reflects the route of
chemokine clearance, as has been shown for IL-8 (Rot, A.,
unpublished data).
To estimate the amount of intracutaneously injected
TCA-4 that reaches plt/plt PLNs, TCA-4 was injected into
the skin over the neck and bilaterally in the ventral fore-
limbs and inner thighs of BALB/c-plt/plt mice. 2 h later, the
TCA-4 concentration in lymphoid organs was determined by
ELISA (Table I). TCA-4 levels in untreated BALB/c-plt/
plt mice were below the detection limit (0.01 ng/mg tissue)
of our assay. In contrast, significant levels of TCA-4 (z20%
of wild-type) were achieved in skin draining PLNs of BALB/
c-plt/plt mice that had received TCA-4 intracutaneously.
TCA-4 was undetectable in most other lymphoid organs,
except the spleen. Interestingly, TCA-4DCT lacking 41
amino acids of the elongated COOH terminus accumu-
lated less in draining LNs or other lymphoid tissues when
an equivalent amount was injected (Table I).
Next, we asked whether intracutaneously injected exog-
enous TCA-4 in draining PLNs can be transported to and
presented within HEVs. We injected 2.5 mg TCA-4 into
the skin over the subiliac LN of plt/plt mice. 30 min later,
the LN was prepared for intravital microscopy. 90–120 min
after chemokine injection, anti–TCA-4 mAb FITC-4B1
was administered intraarterially. In contrast to untreated
plt/plt mice (Fig. 2 C), several venules in draining PLNs of
TCA-4–treated plt/plt mice acquired a faint but detectable
fluorescent signal (Fig. 6 B). No fluorescence was seen in
LN capillaries or arterioles or in skin microvessels (Fig. 6,
C–E). Interestingly, anti–TCA-4 delineated some, but not
all venules in plt/plt PLNs, and a few venules were observed
in which staining appeared to be segmental. These findings
suggest that intracutaneously injected exogenous TCA-4
not only reaches PLNs via afferent lymph, but is also trans-
ported to the luminal surface of some PLN HEVs.
Intracutaneously Injected TCA-4 Reconstitutes LFA-1–medi-
ated Sticking of TGFP Cells in plt/plt HEVs. We investigated
the effect of exogenous TCA-4 on TGFP cell adhesion. For
this, plt/plt animals received intracutaneous injections of ei-
ther 1 mg TCA-4 or 1 mg SDF-1a in 50 ml Ringer’s injec-
tion solution. 30 min later, the draining subiliac LN was
prepared for intravital microscopy, and TGFP cell behavior
in HEVs was recorded 60–90 min thereafter. Rolling frac-
tions remained unchanged compared with untreated plt/plt
mice (Fig. 7, A and B). In contrast, in each of eight PLNs
of TCA-4–treated mice, HEVs were detected that sup-
ported significant sticking of TGFP cells (Fig. 7 D). Overall,
sticking was observed in 13 out of 34 recorded plt/plt
HEVs, with a maximum sticking fraction of 36.7%, a value
that was comparable to sticking fractions in wild-type HEVs
(Fig. 4 C) but was never observed in untreated plt/plt mice
(Fig. 7 C). In contrast, intracutaneous injection of SDF-1a
did not induce T cell arrest, except in one plt/plt mouse
(out of five) in which two HEVs supported some sticking
(Fig. 7, E and F).
To determine whether the effect of intracutaneously in-
jected TCA-4 on TGFP cells was due to LFA-1 activation,
HEVs in TCA-4–treated plt/plt animals were identified
that supported significant sticking of TGFP cells. Subse-
quently, the mice and cells were treated with anti–LFA-1,
and TGFP cell sticking was compared in the same venules.
Inhibition of LFA-1 nearly abrogated TCA-4–induced
TGFP cell sticking in all vessels (Fig. 8).
Discussion
Previous work has shown that lymphocyte homing to
PLNs is mediated by a multistep adhesion and signaling cas-
Table I. TCA-4 Concentration in Lymphoid Organs of BALB/c and BALB/c-plt/plt Mice with or without Intracutaneous Injection of TCA-4 
or TCA-4DCT
Recoverable TCA-4 (ng/mg wet wt)
Tissue BALB/c BALB/c-plt/plt BALB/c-plt/plt 1 TCA-4 i.c. BALB/c-plt/plt 1 TCA-4DCT i.c.
PLN 2.56 6 0.37 ,0.01 0.54 6 0.32 0.04 6 0.01
MLN 4.37 6 1.86 ,0.01 ,0.01 ,0.01
PP 1.87 6 0.50 ,0.01 ,0.01 ,0.01
Thymus 0.78 6 0.25 ,0.01 ,0.01 ,0.01
Spleen 0.20 6 0.14 ,0.01 0.18 6 0.07 0.03 6 0.01
Chemokine concentrations in homogenized lymphoid tissues were measured by capture ELISA. Some BALB/c-plt/plt mice received intracutaneous
(i.c.) injections of a total of 5 mg recombinant murine full-length or truncated TCA-4 distributed to five anatomical sites as described in Materials
and Methods. Tissues were harvested 2 h later, at which time full-length TCA-4 was detectable in draining PLNs (axillary, cervical, and inguinal
LNs) and the spleen, but not in other lymphoid tissues. On the other hand, TCA-4DCT failed to accumulate in draining LNs and other lymphoid
tissues. Results are shown as mean 6 SEM from four to eight mice per group.70 TCA-4 Triggers T Cell Sticking in Lymph Node HEVs
cade (7). Upon entry into HEVs, L-selectin tethers fast mov-
ing cells to PNAd on the endothelial lining. The L-selectin/
PNAd pathway mediates rolling whether the tethered cells
are PLN-homing lymphocytes or leukocytes (e.g., granulo-
cytes) that do not accumulate in normal PLNs (7). The se-
lectivity of lymphocyte recruitment to PLNs has been at-
tributed to the fact that lymphocytes are the predominant
rolling population that can arrest in HEVs. Sticking re-
quires LFA-1, which is found on all leukocytes, but it must
be functionally activated to bind to endothelium. LFA-1
activation in HEVs is known to depend on Gai protein sig-
naling (7, 17, 42). Since neither the primary (L-selectin)
nor the secondary (LFA-1) adhesion receptors are uniquely
expressed on PLN-homing (predominantly naive) lympho-
cytes, it has been proposed that the integrin-activating stimu-
lus, which has been unknown, is critical for the overall
specificity of the adhesion cascade.
Here, we report that constitutively expressed TCA-4 in
PLN HEVs provides a subset-specific signal to rolling T
cells that triggers rapid LFA-1 activation. Several lines of
evidence suggest that TCA-4 is both necessary and suffi-
cient to induce LFA-1–dependent arrest of T cells in PLN
HEVs. First, using immunofluorescence microscopy in live
animals, we found that TCA-4 was presented on the lumi-
nal surface of HEVs. Second, TCA-4–desensitized T cells
failed to stick in wild-type PLNs. Third, PLN HEVs in
plt/plt mice did not express TCA-4 and did not support T
cell sticking, resulting in markedly reduced T cell homing
to PLNs. Finally and most importantly, LFA-1–mediated T
cell arrest was restored in plt/plt PLNs whose HEVs pre-
sented intracutaneously injected exogenous TCA-4. It has
been postulated for some time that chemokines serve as se-
lective triggers of integrin activation during lymphocyte
homing (2, 3, 18, 19). To our knowledge, this is the first
study to provide direct evidence for this concept in vivo.
Our results are consistent with earlier observations that
have led to the speculation that TCA-4 is involved in T
cell homing to PLNs (22, 24, 28, 29, 43). One of the first
clues was the finding that TCA-4 mRNA is constitutively
expressed in HEVs (22). Further, the predominant receptor
for TCA-4 is CCR7, a Gai-linked serpentine glycoprotein
on PLN-tropic T and B cells, not found on granulocytes or
monocytes (24, 25). In vitro, not only is TCA-4 a potent
chemoattractant for B and T cells in assays that last a few
hours (20–24, 43), but it can also induce integrin-mediated
adhesion within seconds (28–30). This is important, con-
sidering the short transit time of lymphocytes through PLN
HEVs (7, 10). Finally, it was shown recently that HEVs in
Figure 7. Intracutaneously injected TCA-4, but not SDF-1a, reconsti-
tutes TGFP cell sticking in plt/plt PLN venules. 1 mg TCA-4 or SDF-1a
was injected intracutaneously in left hind legs of plt/plt mice. Surgical
preparation of the draining left inguinal LN was started 30–40 min after
chemokine injection. TGFP cell behavior was observed in the draining
subiliac PLN 90 min after chemokine injection using intravital micros-
copy. (A) Rolling fractions of TGFP cells in plt/plt PLN venules without
chemokine injection (1) or after injection of 1 mg TCA-4 (m) or SDF-
1a (e) as a function of vessel diameter. (B) Mean rolling fractions of TGFP
cells in plt/plt PLN venules. The rolling frequency was not affected by
chemokines. (C–E) Sticking fractions of TGFP cells in plt/plt PLN venules
without chemokine injection (C) or after pretreatment with TCA-4 (D)
or SDF-1a (E) as a function of the vessel diameter. (F) Mean sticking
fractions of TGFP cells in plt/plt PLN venules. TGFP cells underwent firm
adhesion in some, but not all, HEVs of TCA-4–pretreated plt/plt mice
(*P , 0.008 vs. no chemokine, and P , 0.02 vs. SDF-1a–treated ani-
mals). On the other hand, SDF-1a–pretreated plt/plt PLN venules did
not support firm adhesion of TGFP cells, except in one animal (out of five)
where some sticking was seen in two venules (P 5 0.34 vs. no chemo-
kine). Data are shown as mean 6 SEM; n 5 no. of animals/venules ana-
lyzed. A digitized QuickTime™ video showing T cell rolling and stick-
ing in an HEV of a plt/plt mouse 1 h after intracutaneous injection of
TCA-4 is available at http://www.jem.org/cgi/content/full/191/1/61/
F7/DC1.
Figure 8. TCA-4–induced firm
arrest of TGFP cells in plt/plt HEVs
is LFA-1 dependent. Mean stick-
ing fractions of TGFP cells in plt/
plt HEVs pretreated with TCA-4
before and after anti–LFA-1 mAb
(TIB 213) treatment. After assess-
ment of TGFP cell sticking in the
absence of mAb (control), mice
and GFP-T cells were treated
with anti–LFA-1 mAb and ob-
served in the same HEVs that
supported firm arrest of control
cells. In contrast to untreated TGFP cells, anti–LFA-1 mAb–treated TGFP
cells failed to become firmly adherent (*P , 0.05). Data are shown as
mean 6 SEM; n 5 no. of animals/venules analyzed.71 Stein et al.
plt/plt mice do not contain TCA-4 message (33). Previous
work has demonstrated that T cells home poorly to PLNs
of plt/plt mice, whereas B cell homing is normal. This phe-
notype was due to an autosomal recessive defect affecting
the PLN stroma (31, 32).
Since these earlier findings were suggestive of a role for
TCA-4 during homing of T cells, but not B cells, to PLNs,
we undertook this study. We used a novel strategy to visu-
alize selectively T cells by intravital fluorescence micros-
copy. In previous studies, lymphocyte subpopulations were
isolated and fluorescently labeled to detect adoptively trans-
ferred cells in recipient animals (7, 38, 42, 44). Such ma-
nipulations might alter the function of isolated cells. For
example, we observed that exposure of adoptively trans-
ferred LN cells to cold temperature or culture for several
hours before injection often reduced the cells’ ability to
stick in PLN HEVs (7; and our unpublished data). Such
confounding factors are difficult to avoid when a large
number of homogenous cells must be obtained by conven-
tional isolation methods. Furthermore, contaminating cell
populations can potentially alter the experimental readout.
To circumvent these problems, we used T-GFP mice in
which transgenic GFP is selectively expressed in CD41 and
CD81 T cells (35). Most effector and some memory T cells
in these animals lose GFP expression, whereas cells that ex-
press GFP at detectable levels are naive T cells (35). Single
cell suspensions were generated from LNs of T-GFP donors
and injected into recipients within 1 h after harvesting. Any
transferred non-T cells (as well as the recipients’ own leu-
kocytes) remained invisible when viewed under epifluores-
cent light.
To ensure that transgenic GFP did not alter T cell be-
havior, we performed short-term homing assays and intra-
vital microscopy. Consistent with previous studies on non-
transgenic T cells (31, 32), TGFP cells homed to wild-type
PLNs, but migrated poorly to plt/plt PLNs. TGFP cells ex-
pressed physiological levels of L-selectin (35), and their
rolling fraction in PLN HEVs was comparable to that of
nontransgenic lymphocytes (7, 38), indicating that L-selec-
tin function was normal. Interestingly, sticking fractions of
TGFP cells in wild-type PLN HEVs tended to be higher
than those observed previously with ex vivo–labeled non-
transgenic LN cells (7, 38). This may have had two reasons.
First, the LN cells used in earlier studies contained z30% B
cells, which home at a lower frequency to PLNs than T
cells (45). Although B cells have not been specifically ex-
amined in the PLN model, it is possible that their sticking
fraction is lower, which may have had a diluting effect on
the overall sticking frequency of mixed LN cells. Second,
as discussed above, TGFP cells require only minimal manip-
ulation, whereas nontransgenic lymphocytes must be sub-
jected to procedures that might reduce their ability to en-
gage integrins. The increased capacity of TGFP cells to activate
LFA-1 might thus reflect a more physiological phenotype.
To test TGFP cell responsiveness to TCA-4, we performed
chemotaxis assays across polycarbonate filter membranes
(46). TGFP cells and nontransgenic T cells migrated avidly and
with equivalent frequency toward a TCA-4 gradient. This
response was mediated by TCA-4 binding to CCR7, be-
cause TCA-4–induced T cell migration was abolished when
macrophage inflammatory protein (MIP)-3b, another CCR7
agonist (47), was added to the top chamber (not shown).
TCA-4 can also bind to murine CXCR3, a chemokine re-
ceptor that is reportedly expressed on activated Th1 cells,
but not on naive T cells (48). However, the CXCR3 ago-
nist monokine induced by IFN-g (MIG), did not attract
TGFP cells and did not antagonize TCA-4–induced TGFP cell
migration. Thus, CCR7, and not CXCR3, was the princi-
pal TCA-4 receptor on TGFP cells (not shown).
Having determined that TGFP cells are useful to study the
role of the TCA-4/CCR7 pathway in T cell homing, we
initially treated wild-type mice with anti–TCA-4 mAbs
3D5 and 4B1. Both mAbs block TGFP cell chemotaxis to-
ward TCA-4 in vitro (20; and data not shown). However,
the mAbs did not affect TGFP cell adhesion or homing to
PLNs, even when given at high doses, either alone or in
combination. When anti–TCA-4 mAbs were added at a
concentration that inhibited chemotaxis to L1-2 transfec-
tants expressing murine CCR7, neither blocked TCA-4–
induced intracellular calcium flux (not shown). Thus, the
mAbs did not antagonize TCA-4 binding to or signaling
through CCR7. The mechanism by which they inhibit
chemotaxis is unclear. In any case, our findings indicate
that blocking activities of antibodies against chemokines in
chemotaxis assays must be interpreted with caution. Fur-
thermore, since anti–TCA-4 mAbs did not block TCA-4
signaling via CCR7, the lack of a detectable effect in vivo
does not argue against a role for this pathway in T cell
homing.
Therefore, we explored alternative strategies to address
this question. One approach was to examine the effect of
TCA-4 desensitization. TGFP cells were incubated with
TCA-4 or SDF-1a under conditions that render their respec-
tive receptors, CCR7 and CXCR4, transiently unresponsive,
whereas other chemokine receptors remain functional (24).
Although SDF-1a, a ubiquitously expressed chemokine,
can activate lymphocyte LFA-1 under flow (28), CXCR4-
deficient lymphocytes home efficiently to secondary lymphoid
organs (49). As SDF-1a is thus apparently not essential for
homing to PLNs, we chose it to control for nonspecific ef-
fects that might occur during desensitization. A recent
study reported that lymphocyte desensitization to SDF-1a
inhibits calcium signaling in response to CCR7 stimulation
by MIP-3b (50). However, when we examined L1-2 cells
that expressed CXCR4 and stably transfected murine
CCR7, we found no cross-desensitization between SDF-
1a and TCA-4 in calcium flux assays (not shown). More-
over, SDF-1a did not interfere with T cell chemotaxis
toward TCA-4 (24; and our unpublished data). Thus, desen-
sitization to SDF-1a did not affect the T cell response to
TCA-4 and vice versa. When desensitized TGFP cells were
tested in vivo, rolling was not altered, but TCA-4–desensi-
tized TGFP cells failed to stick in HEVs. Similarly, when
CCR7 was desensitized to MIP-3b, sticking of TGFP cells
was abolished (not shown), indicating that CCR7, but not
CXCR4, is required for T cell arrest in PLN HEVs. This72 TCA-4 Triggers T Cell Sticking in Lymph Node HEVs
cannot be explained by differential expression or signaling
of the two receptors, because both are expressed on naive
T cells (24, 51) and both can induce rapid integrin activa-
tion in vitro (28).
The most likely explanation for these results is that PLN
HEVs contain agonists that stimulate CCR7, but not
CXCR4, on rolling T cells. Indeed, wild-type PLN HEVs
rapidly accumulated circulating fluorescent anti–TCA-4,
indicating that TCA-4 is presented on the luminal surface
of these vessels. The mAb did not delineate arterioles, or
capillaries in PLNs, nor did it stain adjacent skin venules. Thus,
TCA-4 presentation is a specialized feature of HEVs analo-
gous to the expression of PNAd, which shows a similarly
restricted distribution in vivo (38). The fluorescent mAb
was apparently retained in HEVs, suggesting that its antigen
was somehow immobilized, even though TCA-4 is a se-
creted molecule and has no transmembrane domain (20–23).
However, like most chemokines, TCA-4 contains COOH-
terminal binding sites for heparin-like glycosaminoglycans
(GAGs) (20–23). Since sulfated glycosaminoglycans are highly
concentrated in HEVs (52), it is conceivable that TCA-4 is
retained and presented by such molecules. This is consis-
tent with the concept that integrin-activating factors must
be presented to rolling leukocytes in a manner that keeps
them from being dispersed by the flowing blood (53–55).
This notion was underscored by recent experiments with
full-length and COOH-terminally truncated IL-8 in rab-
bits (53). Both activated neutrophils equally well in vitro,
but only the former was presented on the luminal surface of
ECs and promoted neutrophil accumulation upon intracu-
taneous injection, whereas the latter did not (53).
Although our findings with desensitized T cells are con-
sistent with a role for CCR7 in T cell sticking in HEVs,
they cannot distinguish between different CCR7 agonists
(i.e., TCA-4 versus MIP-3b). Also, we cannot rule out
that prolonged exposure to TCA-4 affected the TGFP cells’
response to other chemoattractants. Therefore, we performed
experiments in plt/plt mice. In situ hybridization has shown
that TCA-4 mRNA is absent in plt/plt PLN HEVs (33).
Using immunohistochemistry and in vivo labeling with
fluorescent anti–TCA-4, we show that TCA-4 protein is
also undetectable. Homing assays with TGFP cells further
confirmed the severe defect in T cell recruitment to PLNs
(31, 32). A few TGFP cells were still found in plt/plt PLNs.
Some of these cells may have been localized in blood that
could not be completely removed from the harvested
PLNs. Adding to this background, the percentage of TGFP
cells in plt/plt blood was significantly higher than in wild-
type mice, probably resulting from the inability of TGFP
cells to leave the vascular compartment in plt/plt animals
(31). However, plt/plt PLNs are not entirely devoid of
lymphocytes, but contain essentially normal numbers of B
cells and some T cells that are predominantly of memory
phenotype (32). Thus, alternative mechanisms exist in PLNs
that mediate homing of B cells and possibly also of distinct
(memory) T cell subsets in the absence of TCA-4.
Nevertheless, our intravital microscopy studies clearly
show that naive T cells are incapable of arresting in plt/plt
HEVs, indicating that the plt phenotype is due to a defect
in the transition from L-selectin–mediated rolling to inte-
grin-dependent sticking. However, although TCA-4 is
clearly not expressed in plt/plt PLNs, it cannot be excluded
that the plt mutation also affects other relevant loci besides
TCA-4. For example, the MIP-3b gene lies within 100 kb
of the TCA-4 locus, and MIP-3b mRNA is also somewhat
reduced in plt/plt PLNs (33). In contrast to TCA-4, MIP-
3b is not expressed by HEVs, but by interdigitating DCs (27)
whose migration to the T cell area of plt/plt PLNs is com-
promised (33). While this DC migration defect (which may
be related to the absence of TCA-4) could explain the re-
duction in MIP-3b message, this circumstance complicates
the interpretation of our results. If MIP-3b protein is simi-
larly reduced (this is presently unknown), the lack of this
CCR7 agonist (and/or other DC-derived mediators) could
provide an alternative explanation for the absence of T cell
sticking in plt/plt PLNs.
To obtain direct proof that TCA-4 deficiency is at least
in part responsible for the lack of T cell sticking in plt/plt
HEVs, we set out to reconstitute TCA-4 presentation in
these vessels. This was possible because intracutaneously in-
jected recombinant full-length, but not COOH-terminally
truncated, TCA-4 accumulated rapidly in draining LNs and
was transported to the lumen of some HEVs. Indeed, intra-
cutaneously injected exogenous TCA-4 reconstituted LFA-
1–dependent sticking of TGFP cells in plt/plt PLNs. Al-
though sticking was limited to only about one third of the
observed HEVs, it was significantly higher than in un-
treated or SDF-1a–treated plt/plt mice. Injection of SDF-1a
into the skin of mice has been shown previously to cause a
local inflammatory response (51), but it did not alter TGFP
cell behavior in draining PLNs. Therefore, it seems likely
that TGFP cell sticking in plt/plt PLNs was a direct result of
TCA-4 presentation in HEVs, rather than secondary in-
flammation-induced events that might be elicited by intra-
cutaneous injection of chemokines.
An interesting question is how TCA-4 was transported
from the skin to the luminal surface of PLN HEVs. The ra-
pidity and selectivity at which intracutaneously injected
TCA-4 appeared in PLNs that drained the site of injection
indicate that its primary access route was afferent lymph
vessels. Of note, it has been shown that some CC chemo-
kines bind to dermal lymph vessels, suggesting that lym-
phatic ECs can control the uptake (and possibly drainage) of
certain chemokines (56). It is unknown whether the trans-
port of TCA-4 or SDF-1a is regulated at this level. The
finding that intracutaneously injected TCA-4DCT was barely
detectable in draining PLNs suggests that the elongated
COOH terminus of TCA-4 could be involved. This unex-
pected observation suggests the existence of specific molec-
ular recognition and transportation mechanisms and indicates
that the drainage of TCA-4 (and perhaps other chemo-
kines) to PLNs cannot be explained by mere passive diffu-
sion and lymph flow along hydrostatic pressure gradients.
Once TCA-4 has reached the PLNs, it is apparently
transported to HEVs. One candidate intranodal pathway
may be the fibroblastic reticular cell conduit system, a mesh-73 Stein et al.
work of fiber-like channels that drains afferent lymph fluid
from the subcapsular sinus to the vicinity of HEVs (57, 58).
In addition, some intracutaneously injected TCA-4 can ap-
parently reach the blood either directly or possibly via
lymph drainage through the thoracic duct. This could ex-
plain the appearance of TCA-4 in the spleen of plt/plt mice
2 h after intracutaneous injection. Thus, it cannot be ex-
cluded that blood-borne TCA-4 can also bind to HEVs
and contribute to the reconstitution of sticking. However,
intracutaneously injected TCA-4 accumulated preferen-
tially in draining PLNs where only a subset of HEVs was
stained with anti–TCA-4 mAb and supported sticking of
TGFP cells. This argues against a significant contribution by
blood-borne TCA-4, which should be more evenly dis-
tributed. Rather, this pattern probably reflects restricted
drainage or transport of lymph fluid within the node.
Transport of abluminal TCA-4 to the luminal surface of
HEVs might be achieved by diffusion between adjacent
ECs (57, 58) or, perhaps more likely, by specific transendo-
thelial movement. Endocytotic uptake, transcytosis, and pre-
sentation of chemokines on microvillus-like luminal surface
protrusions were described for IL-8 and regulated upon ac-
tivation, normal T cell expressed and secreted (RANTES)
in skin microvessels (53). Conceivably, the unusually long,
basic COOH terminus of TCA-4 may play a role not only
in transportation from the skin to PLNs, but also in its trans-
location to the luminal surface of HEVs, possibly in con-
junction with specialized proteoglycans. A role for chemo-
kine association with proteoglycans in intracellular vesicles
has been reported in cytolytic T cells (59). In addition, the
COOH terminus might help to retain TCA-4 on the lumi-
nal surface of HEVs complexed to proteoglycans. Accord-
ingly, preliminary experiments suggest that the COOH ter-
minus increases retention of TCA-4 on heparan sulfate (Luo,
Y., unpublished observations).
Since TCA-4 is constitutively synthesized by HEVs, it is
unclear whether its transport via afferent lymph or its trans-
location across the venular wall plays a physiological role in
lymphocyte homing to PLNs. However, it seems likely
that other molecules can share this conduit. For example,
PLN venules require afferent lymph fluid to maintain an
HEV phenotype (60–62). Furthermore, recent findings in-
dicate that mast cell–derived MIP-1b can be transported to
and presented within HEVs in inflamed PLNs (63). MIP-
1b has also been detected in the fibroblastic reticular cell
conduit system (58). We speculate that transportation of
specialized chemokines via afferent lymph constitutes a
“remote control” mechanism that modulates the composi-
tion of leukocyte subsets that are recruited to PLNs.
In conclusion, we report that TCA-4 is presented on the
luminal surface of PLN HEVs where it interacts with
CCR7 on rolling T cells to activate LFA-1–mediated ar-
rest. In this study, we exploited the fact that adoptively
transferred naive T cells from transgenic T-GFP mice can
be readily identified in PLN HEVs. Desensitization of TGFP
cells to TCA-4 abolished LFA-1–dependent sticking in wild-
type HEVs, and untreated TGFP cells did not stick in PLN
HEVs of plt/plt mutant mice, which have a genetic defect
in TCA-4 expression. Indeed, after this paper was accepted
for publication, a report by Vassileva et al. (64) demon-
strated the presence of two TCA-4 genes in mice. Only
one of these genes is expressed in lymphoid tissues. Consis-
tent with the data presented here, it was shown that this gene
is deleted in plt/plt mice, whereas the other (responsible for
TCA-4 expression in some nonlymphoid tissues) remains
intact. TCA-4 presentation, as well as TGFP cell sticking, in
plt/plt PLN HEVs was restored by intracutaneous injection
of TCA-4. Although these results do not exclude a contri-
bution by other chemoattractants to T cell homing to
PLNs, our data suggest that TCA-4 is both necessary and
sufficient to activate integrins on rolling T cells in HEVs.
Since T cell homing to MLNs and PPs is also compromised
in plt/plt mice (32; and data not shown), we propose that
TCA-4 may have a similar role in most secondary lym-
phoid tissues, except the spleen. 
We also demonstrate that chemokines can be transported
over long distances to draining LN HEVs, where they may
have a profound impact on leukocyte recruitment. Further
research will be needed to understand this complex rela-
tionship between PLNs and their micro- and macroenvi-
ronment.
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